FDA Deputy Commissioner Details Agency’s Priorities In Recent Speech

more+
less-

In This Issue:

- Snapshot of the Agency: FDA-regulated products

- Recent Public Health Milestones

- Innovative Programs at FDA

..A. FDA has a number of programs intended to speed the availability of promising new therapies to patents with serious and life-threatening illnesses.

..B. Pediatric & Rare Disease Initiatives

..C. Drug, Biologics & Device Innovation

..D. Advancements in Clinical Trials

- Cross-FDA Alignment Initiatives

- Policy Initiatives Underway

- Excerpt from Snapshot of the Agency: FDA-regulated products:

Products Regulated by FDA Include:

- Human Drugs

- Rx, OTC, Generics

- Vaccines, Blood Products, and Other Biologics

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

FDA

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Polsinelli | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×